Avicanna

Advantage

Advanced Natural
Cannabinoid Solutions

A Leader in Biopharmaceutical Advancements with Natural Cannabinoids

Avicanna is a Canadian vertically-integrated biopharmaceutical company developing and commercializing various cannabinoid-based products for the global market place.

Advanced R&D, pre-clinical and clinical platform

  1. Cannabinoid R&D expertise – Team of 10+ scientists operating with Canadian Cannabis Research Licenses
  1. World-Class collaborations – with leading Canadian academic and clinical institutions
  1. 3 years of IP development – Proprietary methodologies in breeding, cultivation, extraction, formulation & clinical development, and analytical testing

Diversified and high margin income streams

  1. Comprehensive commercial portfolio – across consumer retail, medical cannabis and pharmaceutical market segments
  1. International footprint – multinational operations and commercial sales across US, Canada, LATAM and Europe
  1. Diversified revenue streams – seeds, API, formulations, finished products and licensing of IP

Low-cost vertical integration

  1. 2 Colombian subsidiaries – cultivation footprint of 480,000 sq feet and industrial extraction capacity
  1. Low cost, Organic and sustainable cultivation – ranked highest amongst global cannabis companies in the SAM Corporate Sustainability Assessment issued by S&P Global

Consumer Retail Products

Medical Products

Pharmaceutical Pipeline

Active Pharmaceutical Ingredients

Genetics and Seeds